Skip to main content
TTRX
NASDAQ Life Sciences

GX-03 Hits 59.3% Clear/Almost Clear at Week 4 in Phase 2a

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$9.8
Mkt Cap
$299.22M
52W Low
$2.57
52W High
$16.45
52W Position info
281% above low
Off High info
40% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

TTRX has more than doubled off its 52-week low of $2.57.

Summary

Interim Phase 2a data for GX-03 in atopic dermatitis show 59.3% of patients reaching clear or almost clear skin by week 4 versus 30.4% on vehicle, and 40.7% achieving EASI-100 at week 8 versus 17.4%. The numbers are directionally strong, but the release gives no statistical significance and the dataset is small at n=50. This builds on the interim efficacy signal disclosed in the August 8-K and the stronger presentation update in October, now with actual response rates attached. The company is adaptively refining the Phase 2b design using the first 50 completers, so the next real read is later-stage data. A hidradenitis suppurativa Phase 2a is targeted to enroll its first patient in Q1 2027, a target rather than a confirmed date. With a $5.85M quarterly net loss and going-concern language in the last 10-Q, positive clinical news matters for financing leverage as much as for the program itself.

At the time of this announcement, TTRX was trading at $9.80 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $299.2M. The 52-week trading range was $2.57 to $16.45. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

TTRX - Latest Insights

TTRX
Nov 16, 2026, 4:23 PM EST
Filing Type: 424B3
Importance Score:
7
Price at Filing: $8.55
Real-time Price: $8.00 info
Change: -$0.5475 (-6%) info
Market Cap: $247.486M info
TTRX
Nov 10, 2026, 8:05 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $9.79
Real-time Price: $8.00 info
Change: -$1.79 (-18%) info
Market Cap: $247.486M info
TTRX
Nov 09, 2026, 8:05 AM EST
Filing Type: S-3
Importance Score:
7
Price at Filing: $9.48
Real-time Price: $8.00 info
Change: -$1.48 (-16%) info
Market Cap: $247.486M info
TTRX
Nov 09, 2026, 8:00 AM EST
Filing Type: S-3
Importance Score:
8
Price at Filing: $9.48
Real-time Price: $8.00 info
Change: -$1.48 (-16%) info
Market Cap: $247.486M info
TTRX
Nov 09, 2026, 7:02 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $9.48
Real-time Price: $8.00 info
Change: -$1.48 (-16%) info
Market Cap: $247.486M info